文献

J-GLOBAL ID：201702233567767897   整理番号：17A0135946

高用量糖質コルチコイドで治療した全身リウマチ疾患患者におけるアレンドロネートを用いた初期段階の骨代謝の分析および初期介入の臨床的利点:日本での骨粗鬆症の初期診断と治療(EDITOR-J)試験

Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study

著者 (16件)： Tanaka Yoshiya (First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) ,  Mori Hiroko (First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) ,  Aoki Takatoshi (Department of Radiology, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) ,  Atsumi Tatsuya (Department of Internal Medicine, Hokkaido University, Sapporo, Japan) ,  Kawahito Yutaka (Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Nakayama Hisanori (Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Sagamihara, Kanagawa, Japan) ,  Tohma Shigeto (Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Sagamihara, Kanagawa, Japan) ,  Yamanishi Yuji (Department of Rheumatology, Hiroshima Rheumatology Clinic, Hiroshima, Japan) ,  Hasegawa Hitoshi (Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Ehime, Japan) ,  Tanimura Kazuhide (Hokkaido Medical Center for Rheumatic Diseases, Sapporo, Japan) ,  Negoro Nobuo (Clinical Immunology and Rheumatology, Osaka City University, Osaka, Japan) ,  Ueki Yukitaka (Department of Internal Medicine, Sasebo Central Hospital, Nagasaki, Japan) ,  Kawakami Atsushi (Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Eguchi Katsumi (Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Saito Kazuyoshi (First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan) ,  Okada Yosuke (First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan)
資料名： Journal of Bone and Mineral Metabolism  (Journal of Bone and Mineral Metabolism)
巻： 34  号： 6  ページ： 646-654  発行年： 2016年 
JST資料番号： L0163A  ISSN： 0914-8779  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 高用量糖質コルチコイド治療開始後の全身結合組織疾患患者での骨...

シソーラス用語： グルココルチコイド ,...
準シソーラス用語： 高用量 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0135946&from=J-GLOBAL&jstjournalNo=L0163A") }}

著者キーワード (4件)： Autoimmune disease ,  Alendronate ,  Glucocorticoid ,  Osteoporosis

分類 (3件)： 運動器系疾患の薬物療法  (GG05020D) ,  その他の代謝作用薬の臨床への応用  (GW13070T) ,  疫学  (GB03000E)

物質索引 (2件)： アレンドロネート ,  アルファカルシドール

引用文献 (22件)：

• Weinstein RS (2011) Glucocorticoid-induced bone disease. N Engl J Med 365:62-70
• van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 13:777-787
• LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39-51
• Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y; Subcommittee to Study Diagnostic for Glucocorticoid-Induced Osteoporosis (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of The Japanese Society for Bone and Mineral Research (2004 edition). J Bone Miner Metab 23:105-109
• Soen S, Tanaka Y (2005) Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management. Mod Rheumatol 15:163-168

タイトルに関連する用語 (17件)： 高用量 ,  糖質コルチコイド ,  治療 ,  全身 ,  リウマチ ,  疾患患者 ,  アレンドロネート ,  初期段階 ,  骨代謝 ,  分析 ,  初期 ,  臨床 ,  利点 ,  日本 ,  骨粗鬆症 ,  初期診断 ,  試験